Latest News in the Life Sciences Industry
GlobeNewswire
Clear route to registration positions lucerastat as the potential first oral therapy for all patients with Fabry disease
06 Feb 2026
GlobeNewswire
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
05 Feb 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
05 Feb 2026



